156 related articles for article (PubMed ID: 29287592)
1. Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma.
Gao Y; Huang P; Zhang J
J Transl Med; 2017 Dec; 15(1):268. PubMed ID: 29287592
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
Gao Y; Lu X
Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer.
Dong Z; Zhang A; Liu S; Lu F; Guo Y; Zhang G; Xu F; Shi Y; Shen S; Liang J; Guo W
Mol Cancer Res; 2017 Jul; 15(7):800-810. PubMed ID: 28539329
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of adenosine-mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells.
Liu LX; Deng W; Zhou XT; Chen RP; Xiang MQ; Guo YT; Pu ZJ; Li R; Wang GF; Wu LF
Int J Oncol; 2016 Jan; 48(1):421-9. PubMed ID: 26647875
[TBL] [Abstract][Full Text] [Related]
8. [DNMT1 protein promotes retinoblastoma proliferation by silencing MEG3 gene].
Gao Y; Luo X; Meng T; Zhu M; Tian M; Lu X
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1239-1245. PubMed ID: 32990237
[TBL] [Abstract][Full Text] [Related]
9. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma.
Guo W; Dong Z; Liu S; Qiao Y; Kuang G; Guo Y; Shen S; Liang J
Mol Carcinog; 2017 Aug; 56(8):1924-1934. PubMed ID: 28345805
[TBL] [Abstract][Full Text] [Related]
11. Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
Kruer TL; Dougherty SM; Reynolds L; Long E; de Silva T; Lockwood WW; Clem BF
PLoS One; 2016; 11(11):e0166363. PubMed ID: 27832204
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21.
Li Z; Yang L; Liu X; Nie Z; Luo J
Biomed Pharmacother; 2018 Aug; 104():181-192. PubMed ID: 29772439
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
Modali SD; Parekh VI; Kebebew E; Agarwal SK
Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of long non-coding RNA MEG3 in nasopharyngeal carcinoma.
Chak WP; Lung RW; Tong JH; Chan SY; Lun SW; Tsao SW; Lo KW; To KF
Mol Carcinog; 2017 Mar; 56(3):1041-1054. PubMed ID: 27597634
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
16. [Reversal effect of 5-aza-2-deoxycytidine on the maternally expressed gene 3 promoter hypermethylation and its inhibitory effect on the proliferation of epithelial ovarian cancer cells].
Li J; Zhou D; Wang Z; Tan L; Zhou Y; Li J; Sheng X
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):324-9. PubMed ID: 26463020
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
[TBL] [Abstract][Full Text] [Related]
18. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
Yin DD; Liu ZJ; Zhang E; Kong R; Zhang ZH; Guo RH
Tumour Biol; 2015 Jun; 36(6):4851-9. PubMed ID: 25636452
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of adenomatosis polyposis coli-2 and its tumor suppressor role in retinoblastoma.
Beta M; Chitipothu S; Khetan V; Biswas J; Krishnakumar S
Curr Eye Res; 2015 Jul; 40(7):719-28. PubMed ID: 25207834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]